Alexander Dodoo
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Malaria Research and Control 6
- Pharmaceutical Quality and Counterfeiting 5
- Toxicology 11
- Pharmacovigilance and Adverse Drug Reactions 11
- Co-authors
- William Kudzi (4 shared papers)Jeremy Mills (2 shared papers)Hubert G. M. Leufkens (8 shared papers)Shanthi Pal (3 shared papers)Sten Olsson (2 shared papers)Margareth Ndomondo-Sigonda (2 shared papers)Jacqui Miot (2 shared papers)Shan Naidoo (2 shared papers)
- Journals
- Drug Safety (15 papers)Malaria Journal (5 papers)BMC Public Health (3 papers)Vaccine (2 papers)Therapeutic Advances in Drug Safety (2 papers)
- Partner nations
- GhanaNetherlandsUnited States
In The Last Decade
Alexander Dodoo
45 papers receiving 921 citations
Peers
Comparison fields: 5 of 112
- Toxicology 258
- Applied Microbiology and Biotechnology 28
- Pharmacology 111
- Geriatrics and Gerontology 38
- Infectious Diseases 156
Countries citing papers authored by Alexander Dodoo
This map shows the geographic impact of Alexander Dodoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Dodoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Dodoo more than expected).
Fields of papers citing papers by Alexander Dodoo
This network shows the impact of papers produced by Alexander Dodoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Dodoo. The network helps show where Alexander Dodoo may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Dodoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 126 | |
| 2 | 2017 | 106 | |
| 3 | 2009 | 76 | |
| 4 | 2011 | 71 | |
| 5 | 2017 | 62 | |
| 6 | 2010 | 54 | |
| 7 | 2018 | 30 | |
| 8 | 2014 | 27 | |
| 9 | 2008 | 27 | |
| 10 | 2013 | 24 | |
| 11 | 2015 | 23 | |
| 12 | 2011 | 22 | |
| 13 | 2016 | 20 | |
| 14 | 2013 | 20 | |
| 15 | 2010 | 19 | |
| 16 | 2007 | 18 | |
| 17 | 2015 | 17 | |
| 18 | 2014 | 16 | |
| 19 | 2000 | 15 | |
| 20 | 2019 | 14 |
About Alexander Dodoo
Alexander Dodoo is a scholar working on Public Health, Environmental and Occupational Health, Toxicology, Infectious Diseases, Health and Economics and Econometrics, having authored 46 papers that have together received 959 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (11 papers), Vaccine Coverage and Hesitancy (8 papers), Malaria Research and Control (6 papers), Pharmaceutical Economics and Policy (6 papers), Pharmaceutical Quality and Counterfeiting (5 papers), Influenza Virus Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). The work is most often cited by research in Toxicology (258 citations), Applied Microbiology and Biotechnology (28 citations), Pharmacology (111 citations), Geriatrics and Gerontology (38 citations) and Infectious Diseases (156 citations). Alexander Dodoo has collaborated with scholars based in Ghana, Netherlands and United States. Frequent co-authors include William Kudzi, Jeremy Mills, Hubert G. M. Leufkens, Shanthi Pal, Sten Olsson, Margareth Ndomondo-Sigonda, Jacqui Miot, Shan Naidoo, Eliangiringa Kaale and Jarno Hoekman. Their work appears in journals such as Drug Safety, Malaria Journal, BMC Public Health, Vaccine and Therapeutic Advances in Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.